@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<http://hl7.eu/fhir/ig/gravitate-health/Bundle/33d34b6a-afaf-47d9-8848-366768bd429a> a fhir:Bundle;
  fhir:nodeRole fhir:treeRoot;
  fhir:Resource.id [ fhir:value "33d34b6a-afaf-47d9-8848-366768bd429a"];
  fhir:Bundle.identifier [
     fhir:Identifier.system [ fhir:value "https://www.gravitatehealth.eu/sid/doc" ];
     fhir:Identifier.value [ fhir:value "4291012F1022_4_02" ]
  ];
  fhir:Bundle.type [ fhir:value "document"];
  fhir:Bundle.timestamp [ fhir:value "2002-08-01T13:28:17Z"^^xsd:dateTime];
  fhir:Bundle.entry [
     fhir:index 0;
     fhir:Bundle.entry.resource [
       a fhir:Composition;
       fhir:Resource.id [ fhir:value "aromasin-jpi-bundle-jp" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Composition-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Composition-uv-epi>
         ]
       ];
       fhir:Resource.language [ fhir:value "ja" ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"ja\" lang=\"ja\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"aromasin-jpi-bundle-jp\"  (Language \"ja\") </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Composition-uv-epi.html\">Composition (ePI)</a></p></div><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000155538)</span></p><p><b>date</b>: 2002-08-01 01:28:17+0000</p><p><b>author</b>: <a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></p><p><b>title</b>: TEST PURPOSES ONLY - Aromasin (exemestane) Tablets 25 mg tablets</p><p><b>confidentiality</b>: U</p><h3>Attesters</h3><table class=\"grid\"><tr><td>-</td><td><b>Mode</b></td><td><b>Time</b></td></tr><tr><td>*</td><td>Official <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-composition-attestation-mode.html\">CompositionAttestationMode</a>#official)</span></td><td>2002-08-01 01:28:17+0000</td></tr></table></div>"
       ];
       fhir:Composition.status [ fhir:value "final" ];
       fhir:Composition.type [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/" ];
           fhir:Coding.code [ fhir:value "100000155538" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Package Leaflet" ]
       ];
       fhir:Composition.subject [
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/15c6f86f-8665-4bd6-86da-a3a61fe16084>;
         fhir:Reference.reference [ fhir:value "RegulatedAuthorization/15c6f86f-8665-4bd6-86da-a3a61fe16084" ]
       ];
       fhir:Composition.date [ fhir:value "2002-08-01T13:28:17Z"^^xsd:dateTime ];
       fhir:Composition.author [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
         fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
       ];
       fhir:Composition.title [ fhir:value "TEST PURPOSES ONLY - Aromasin (exemestane) Tablets 25 mg tablets" ];
       fhir:Composition.confidentiality [ fhir:value "U" ];
       fhir:Composition.attester [
         fhir:index 0;
         fhir:Composition.attester.mode [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "http://hl7.org/fhir/composition-attestation-mode" ];
             fhir:Coding.code [ fhir:value "official" ]
           ]
         ];
         fhir:Composition.attester.time [ fhir:value "2002-08-01T13:28:17Z"^^xsd:dateTime ]
       ];
       fhir:Composition.section [
         fhir:index 0;
         fhir:Composition.section.title [ fhir:value "アロマターゼ阻害剤/閉経後乳癌治療剤" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "0" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "アロマターゼ阻害剤/閉経後乳癌治療剤" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>アロマターゼ阻害剤/閉経後乳癌治療剤</p><p>エキセメスタン錠</p><p><img src=\"figure0-aromasin-header.png\" alt=\"Aromasin Tablets 25mg\"/></p></div>"
         ]
       ], [
         fhir:index 1;
         fhir:Composition.section.title [ fhir:value "1. 警告" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "1" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "1. 警告" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
         ];
         fhir:Composition.section.emptyReason [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "1" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
         ]
       ], [
         fhir:index 2;
         fhir:Composition.section.title [ fhir:value "2. 禁忌(次の患者には投与しないこと)" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "2" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "禁忌(次の患者には投与しないこと)" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
         ];
         fhir:Composition.section.section [
           fhir:index 0;
           fhir:Composition.section.title [ fhir:value "2.1" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "2.1" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "2.1" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>妊婦又は妊娠している可能性のある女性[9.5参照]</p></div>"
           ]
         ], [
           fhir:index 1;
           fhir:Composition.section.title [ fhir:value "2.2" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "2.2" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "2.2" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>授乳婦[9.6参照]</p></div>"
           ]
         ], [
           fhir:index 2;
           fhir:Composition.section.title [ fhir:value "2.3" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "2.3" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "2.3" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>本剤の成分に対し過敏症の既往歴のある患者</p></div>"
           ];
           fhir:Composition.section.emptyReason [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "1" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
           ]
         ]
       ], [
         fhir:index 3;
         fhir:Composition.section.title [ fhir:value "3. 組成・性状" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "3" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "3. 組成・性状" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
         ];
         fhir:Composition.section.section [
           fhir:index 0;
           fhir:Composition.section.title [ fhir:value "3.1 組成" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "3.1" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "3.1 組成" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table border=\"1\" width=\"100%\"><tr><td style=\"text-align:center\"><p>販売名</p></td><td style=\"text-align:center\"><p>アロマシン錠 25mg</p></td></tr><tr><td style=\"text-align:center\"><p>有 効 成 分</p></td><td style=\"text-align:center\"><p>1錠中 エキセメスタン 25.000mg</p></td></tr><tr><td style=\"text-align:center\"><p>添 加 剤</p></td><td><p>カルナウバロウ、デンプングリコール酸ナトリウム、クロスポビドン、軽 質無水ケイ酸、結晶セルロース、合成ワックス、酸化チタン、シリコン消 泡剤、ステアリン酸マグネシウム、精製白糖、タルク、炭酸マグネシウム、 パラオキシ安息香酸メチル、ヒプロメロース、ポリソルベート80、ポリビ ニルアルコール(部分けん化物)、ポリエチレングリコール6000NF、D-マ ンニトール</p></td></tr></table></div>"
           ]
         ], [
           fhir:index 1;
           fhir:Composition.section.title [ fhir:value "3.2 製剤の性状" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "3.2" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "3.2 製剤の性状" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table border=\"1\" width=\"100%\"><tr><td colspan=\"3\" style=\"text-align:center\"><p>外 形</p></td><td rowspan=\"2\" style=\"text-align:center\"><p>識別コード</p></td><td rowspan=\"2\" style=\"text-align:center\"><p>色調等</p></td></tr><tr><td style=\"text-align:center\"><p>上面</p></td><td style=\"text-align:center\"><p>下面</p></td><td style=\"text-align:center\"><p>側面</p></td></tr><tr><td style=\"text-align:center\"><p><img alt=\"Aromasin Tablets 25mg\" src=\"aromasin-tablet-shape-above.png\"/></p></td><td style=\"text-align:center\"><p><img alt=\"Aromasin Tablets 25mg\" src=\"aromasin-tablet-shape-under.png\"/></p></td><td style=\"text-align:center\"><p><img alt=\"Aromasin Tablets 25mg\" src=\"aromasin-tablet-shape-side.png\"/></p></td><td rowspan=\"3\" style=\"text-align:center\"><p>7663</p></td><td rowspan=\"3\" style=\"text-align:center\"><p>白色~微灰白色</p><p>糖衣錠</p><p></p></td></tr><tr><td style=\"text-align:center\"><p>直径</p></td><td style=\"text-align:center\"><p>厚さ</p></td><td style=\"text-align:center\"><p>重量</p></td></tr><tr><td style=\"text-align:center\"><p>6.0mm</p></td><td style=\"text-align:center\"><p>4.0mm</p></td><td style=\"text-align:center\"><p>100mg</p></td></tr></table></div>"
           ]
         ]
       ], [
         fhir:index 4;
         fhir:Composition.section.title [ fhir:value "4. 効能又は効果" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "4" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "効能又は効果" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">閉経後乳癌</div>"
         ]
       ], [
         fhir:index 5;
         fhir:Composition.section.title [ fhir:value "5. 効能又は効果に関連する注意" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "5" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "効能又は効果に関連する注意" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
         ];
         fhir:Composition.section.emptyReason [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "1" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
         ]
       ], [
         fhir:index 6;
         fhir:Composition.section.title [ fhir:value "6. 用法及び用量" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "6" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "用法及び用量" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">通常、成人にはエキセメスタンとして1日1回25mgを食後に経口投 与する。</div>"
         ]
       ], [
         fhir:index 7;
         fhir:Composition.section.title [ fhir:value "7. 用法及び用量に関連する注意" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "7" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "7. 用法及び用量に関連する注意" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
         ];
         fhir:Composition.section.emptyReason [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "1" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
         ]
       ], [
         fhir:index 8;
         fhir:Composition.section.title [ fhir:value "8. 重要な基本的注意" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "8" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "重要な基本的注意" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p></p></div>"
         ];
         fhir:Composition.section.section [
           fhir:index 0;
           fhir:Composition.section.title [ fhir:value "8.1" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "8.1" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "8.1" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">本剤はホルモン療法剤であり、がんに対する薬物療法について十 分な知識・経験を持つ医師のもとで、本剤による治療が適切と判断 される患者についてのみ使用すること。</div>"
           ]
         ], [
           fhir:index 1;
           fhir:Composition.section.title [ fhir:value "8.2" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "8.2" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "8.2" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">本剤は末梢アロマターゼを阻害することにより治療効果を発揮す るものであり、活発な卵巣機能を有する閉経前の患者ではアロマ ターゼを阻害する効果は不十分であると予想されること、並びに閉 経前の患者では使用経験がないことを考慮して、閉経前患者に対し 使用しないこと。</div>"
           ]
         ], [
           fhir:index 2;
           fhir:Composition.section.title [ fhir:value "8.3" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "8.3" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "8.3" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">本剤の投与によって、骨粗鬆症、骨折が起こりやすくなるので、 骨密度等の骨状態を定期的に観察することが望ましい。</div>"
           ]
         ], [
           fhir:index 3;
           fhir:Composition.section.title [ fhir:value "8.4" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "8.4" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "8.4" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">本剤の使用による嗜眠、傾眠、無力(症)及びめまいが報告され ており、このような症状がある場合、機械操作や自動車の運転はさ せないよう十分注意すること。</div>"
           ]
         ]
       ], [
         fhir:index 9;
         fhir:Composition.section.title [ fhir:value "9. 特定の背景を有する患者に関する注意" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "9" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "特定の背景を有する患者に関する注意" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p></p></div>"
         ];
         fhir:Composition.section.section [
           fhir:index 0;
           fhir:Composition.section.title [ fhir:value "9.2 腎機能障害患者" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "9.2" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "9.2 腎機能障害患者" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
           ];
           fhir:Composition.section.section [
             fhir:index 0;
             fhir:Composition.section.title [ fhir:value "9.3.1 重度の肝障害のある患者" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "9.3.1" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "9.3.1 重度の肝障害のある患者" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">本剤の重度の肝障害患者における長期安全性を指標とした臨床試験 は実施していない。</div>"
             ]
           ]
         ], [
           fhir:index 1;
           fhir:Composition.section.title [ fhir:value "9.2.1 重度の腎障害のある患者" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "9" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "9.2.1 重度の腎障害のある患者" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">本剤の重度の腎障害患者における長期安全性を指標とした臨床試験 は実施していない。</div>"
           ]
         ], [
           fhir:index 2;
           fhir:Composition.section.title [ fhir:value "9.3 肝機能障害患者" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "9.3" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "9.3 肝機能障害患者" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
           ]
         ], [
           fhir:index 3;
           fhir:Composition.section.title [ fhir:value "9.4" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "9.4" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "9.4" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
           ]
         ], [
           fhir:index 4;
           fhir:Composition.section.title [ fhir:value "9.5 妊婦" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "9" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "9.5 妊婦" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">妊婦又は妊娠している可能性のある女性には投与しないこと。本剤 は、閉経後の患者を対象とするため、妊婦に対する投与は想定され ていないが、妊婦への投与の安全性については次の知見がある。動 物実験(ラット)で、分娩障害、妊娠期間の延長、吸収胚数の増加 及び生存胎児数の減少が認められている。また動物実験(ウサギ)で、 流産、吸収胚数の増加及び胎児体重の低下が認められている。しか し両種による動物実験で、催奇形性は認められてはいない。本剤の 妊婦又は妊娠している可能性のある女性における臨床使用経験はな い。[2.1参照]</div>"
           ]
         ], [
           fhir:index 5;
           fhir:Composition.section.title [ fhir:value "9.6 授乳婦" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "9.6" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "9.6 授乳婦" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">投与しないこと。本剤は、閉経後の患者を対象とするため、授乳婦に 対する投与は想定されていないが、授乳婦への投与の安全性について は次の知見がある。動物実験(ラット)で乳汁中への移行が認められ ている。本剤の授乳中の女性における臨床使用経験はない。[2.2参照]</div>"
           ]
         ]
       ], [
         fhir:index 10;
         fhir:Composition.section.title [ fhir:value "10. 相互作用" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "10" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "10. 相互作用" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p></p></div>"
         ];
         fhir:Composition.section.section [
           fhir:index 0;
           fhir:Composition.section.title [ fhir:value "10.1" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "9" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "10.1" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
           ];
           fhir:Composition.section.emptyReason [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "1" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
           ]
         ], [
           fhir:index 1;
           fhir:Composition.section.title [ fhir:value "10.2 併用注意(併用に注意すること)" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "10" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "10.2 併用注意(併用に注意すること)" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table border=\"1\"><tr><td><p>>薬剤名等</p></td><td><p>臨床症状・措置方法</p></td><td><p>機序・危険因子</p></td></tr><tr><td><p>エストロゲン含有製剤</p></td><td><p>本剤の効果を減弱させる可</p><p>能性がある。</p></td><td><p>本剤の薬理作用はエストロゲン</p><p>合成阻害によるものであるため。</p></td></tr></table></div>"
           ]
         ]
       ], [
         fhir:index 11;
         fhir:Composition.section.title [ fhir:value "11. 副作用" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "11" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "11. 副作用" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>次の副作用があらわれることがあるので、観察を十分に行い、異常 が認められた場合には投与を中止するなど適切な処置を行うこと。</p></div>"
         ];
         fhir:Composition.section.section [
           fhir:index 0;
           fhir:Composition.section.title [ fhir:value "11.1 重大な副作用" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "11.1" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "11.1 重大な副作用" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
           ];
           fhir:Composition.section.section [
             fhir:index 0;
             fhir:Composition.section.title [ fhir:value "11.1.1" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "11.1.1" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "11.1.1" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">肝炎(頻度不明)、肝機能障害(頻度不明)、黄疸(頻度不明) 肝炎、AST、ALT、Al-P、 γ-GTP等の上昇を伴う肝機能障害、 黄疸があらわれることがある。</div>"
             ]
           ]
         ], [
           fhir:index 1;
           fhir:Composition.section.title [ fhir:value "11.2 その他の副作用" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "11.2" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "11.2 その他の副作用" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table border=\"1\"><tbody><tr><td></td><td><p>5%以上</p></td><td><p>0.1~5%未満</p></td><td><p>頻度不明</p></td></tr><tr><td><p>精神神経系</p></td><td><p>多汗、めまい</p></td><td><p>しびれ(感)、頭痛、知覚障害、 ふらつき(感)、不眠(症)、 抑うつ、不安、手根管症候群</p></td><td><p>傾眠</p></td></tr><tr><td><p>消化器</p></td><td><p>悪心</p></td><td><p>食欲不振、腹痛、嘔吐、腸管 閉塞、のどの通過障害感、胃 もたれ感、心窩部痛(心窩部 の疼痛)、下痢</p></td><td></td></tr><tr><td><p>肝臓</p></td><td></td><td></td><td><p>肝機能異常、Al-P 上昇</p></td></tr><tr><td><p>皮膚</p></td><td></td><td><p>発疹、脱毛(症)、爪の変化</p></td><td><p>蕁麻疹、そう痒症</p></td></tr><tr><td><p>筋骨格系</p></td><td></td><td><p>関節痛、筋骨格痛</p></td><td><p>骨折、骨粗鬆症、弾 発指、狭窄性腱鞘炎</p></td></tr><tr><td><p>循環器</p></td><td><p>高血圧</p></td><td><p>動悸、低血圧</p></td><td></td></tr><tr><td><p>呼吸器</p></td><td></td><td><p>鼻出血、かぜ症候群、肺炎</p></td><td></td></tr><tr><td><p>泌尿器</p></td><td></td><td><p>膀胱炎、尿検査異常</p></td><td></td></tr><tr><td><p>生殖器</p></td><td></td><td><p>不正(子宮)出血、帯下</p></td><td></td></tr><tr><td><p>その他</p></td><td><p>ほてり、疲労</p></td><td><p>疼痛、体重減少、倦怠(感)、体臭、</p><p>浮腫、味覚異常、嗅覚障害</p></td><td><p>過敏症</p></td></tr></tbody></table></div>"
           ]
         ]
       ], [
         fhir:index 12;
         fhir:Composition.section.title [ fhir:value "12. 臨床検査結果に及ぼす影響" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "12" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "12. 臨床検査結果に及ぼす影響" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p></p></div>"
         ];
         fhir:Composition.section.emptyReason [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "1" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
         ]
       ], [
         fhir:index 13;
         fhir:Composition.section.title [ fhir:value "13. 過量投与" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "13" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "13. 過量投与" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p></p></div>"
         ];
         fhir:Composition.section.emptyReason [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "1" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
         ]
       ], [
         fhir:index 14;
         fhir:Composition.section.title [ fhir:value "14. 適用上の注意" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "14" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "14. 適用上の注意" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p></p></div>"
         ];
         fhir:Composition.section.section [
           fhir:index 0;
           fhir:Composition.section.title [ fhir:value "14.1 薬剤交付時の注意" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "14.1" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "14.1 薬剤交付時の注意" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">PTP包装の薬剤はPTPシートから取り出して服用するよう指導するこ と。PTPシートの誤飲により、硬い鋭角部が食道粘膜へ刺入し、更に は穿孔をおこして縦隔洞炎等の重篤な合併症を併発することがある。</div>"
           ]
         ]
       ], [
         fhir:index 15;
         fhir:Composition.section.title [ fhir:value "15. その他の注意" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "13" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "15. その他の注意" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p></p></div>"
         ];
         fhir:Composition.section.emptyReason [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "2" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "Section Heading" ]
         ];
         fhir:Composition.section.section [
           fhir:index 0;
           fhir:Composition.section.title [ fhir:value "15.1" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "13" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "15.1" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
           ];
           fhir:Composition.section.emptyReason [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "1" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
           ]
         ], [
           fhir:index 1;
           fhir:Composition.section.title [ fhir:value "15.2 非臨床試験に基づく情報" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "13" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "15.2 非臨床試験に基づく情報" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>24ヵ月間のマウスがん原性試験において、中用量(150mg/kg/日)、 高用量(450mg/kg/日)で雌雄において肝細胞腺腫及び肝細胞癌の 発生率の上昇が認められた。また、雄の高用量群で腎腺腫の発生の 上昇がみられた。これらの腫瘍はマウス特有なものである可能性が 高くヒトにおける臨床的な安全性との関連は低いと考えられる1)。</p></div>"
           ]
         ]
       ], [
         fhir:index 16;
         fhir:Composition.section.title [ fhir:value "16. 薬物動態" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "13" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "16. 薬物動態" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
         ];
         fhir:Composition.section.emptyReason [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "2" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "Section Heading" ]
         ];
         fhir:Composition.section.section [
           fhir:index 0;
           fhir:Composition.section.title [ fhir:value "16.1 血中濃度" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "13" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "16.1 血中濃度" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>日本人の閉経後進行乳癌患者にエキセメスタン25mgを1日1回反復投与したと き、tmaxは2.01±1.35時間、Cmaxは27.4±16.6ng/mL、AUCは115±76ng・h/mL、 終末相のt1/2は20.2±11.7時間であった。血漿中エキセメスタン濃度推移を下図 に示す。</p><p><img src=\"figure1-aromasin-plasma-concentration.png\"/></p><p>図 日本人閉経後進行乳癌患者にエキセメスタン25mgを1日1回29日間反復投 与した後の血漿中エキセメスタン濃度推移(n=15~16、平均値±標準偏差)</p><p>日本人の閉経後健康成人女性に単回及び反復経口投与(0.5~50mg)後のエ キセメスタンのCmax及びAUCは用量比例的であった2~4)。</p></div>"
           ]
         ], [
           fhir:index 1;
           fhir:Composition.section.title [ fhir:value "16.2 吸収" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "13" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "16.2 吸収" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
           ];
           fhir:Composition.section.emptyReason [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "2" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "Section Heading" ]
           ];
           fhir:Composition.section.section [
             fhir:index 0;
             fhir:Composition.section.title [ fhir:value "16.2.1 食事の影響" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "13" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "16.2.1 食事の影響" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>エキセメスタン25mgを閉経後健康女性(欧米人)に高脂肪食摂取直後に投与 した時、Cmax及びAUCの平均値は空腹投与時に比べそれぞれ25%及び39%上 昇した2)。</p></div>"
             ]
           ]
         ], [
           fhir:index 2;
           fhir:Composition.section.title [ fhir:value "16.3 分布" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "13" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "16.3 分布" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
           ];
           fhir:Composition.section.emptyReason [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "2" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "Section Heading" ]
           ];
           fhir:Composition.section.section [
             fhir:index 0;
             fhir:Composition.section.title [ fhir:value "16.3.1 組織内濃度" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "13" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "16.3.1 組織内濃度" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>雌性ラットに14C-エキセメスタン1mg/kgを単回経口投与した後、放射能は組 織中に広範囲に分布し、大部分の組織で投与後1あるいは6時間に最高放射能 濃度を示した。肝臓、腎臓及び皮膚を除いた他の組織からの放射能の消失は 速やかであった5)。</p></div>"
             ]
           ], [
             fhir:index 1;
             fhir:Composition.section.title [ fhir:value "16.3.2 胎児・胎盤移行性" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "13" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "16.3.2 胎児・胎盤移行性" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>妊娠ラットに14C-エキセメスタンを経口投与した後の放射能は、胎盤を通過 し胎児に分布した5)。</p></div>"
             ]
           ], [
             fhir:index 2;
             fhir:Composition.section.title [ fhir:value "16.3.3 蛋白結合率" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "13" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "16.3.3 蛋白結合率" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>健康成人女性の血漿を用いたin vitroにおけるエキセメスタンの蛋白結合率は 約96%であった。結合蛋白質はヒト血清アルブミン及びα1-酸性糖蛋白質と 考えられた6)。</p></div>"
             ]
           ]
         ], [
           fhir:index 3;
           fhir:Composition.section.title [ fhir:value "16.5 排泄" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "13" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "16.5 排泄" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
           ];
           fhir:Composition.section.emptyReason [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "2" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "Section Heading" ]
           ];
           fhir:Composition.section.section [
             fhir:index 0;
             fhir:Composition.section.title [ fhir:value "16.5.1" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "13" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "16.5.1" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>14C標識したエキセメスタンを閉経後の外国人健康女性に投与後、168時 間までの放射能の尿中及び糞中の累積排泄量はそれぞれ42±3%及び42±6% であった。尿中に未変化体として排泄された量は、投与量の1%未満であった8)。</p></div>"
             ]
           ], [
             fhir:index 1;
             fhir:Composition.section.title [ fhir:value "16.5.2" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "13" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "16.5.2" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>分娩後の哺育中ラットに14C-エキセメスタン1mg/kgを経口投与した後 の乳汁中放射能濃度は投与後6時間で最高濃度を示した。同時に測定した血 漿中濃度と比較すると、6時間以降では乳汁中濃度の方が高濃度を示すもの の、同様な推移で減少した5)。</p></div>"
             ]
           ]
         ], [
           fhir:index 4;
           fhir:Composition.section.title [ fhir:value "16.6 特定の背景を有する患者" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "13" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "16.6 特定の背景を有する患者" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
           ];
           fhir:Composition.section.emptyReason [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "2" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "Section Heading" ]
           ];
           fhir:Composition.section.section [
             fhir:index 0;
             fhir:Composition.section.title [ fhir:value "16.6.1 腎機能障害患者における体内動態" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "13" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "16.6.1 腎機能障害患者における体内動態" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>中等度又は重度の腎機能障害患者(欧米人の閉経後女性、クレアチニンクリ アランス&lt;60mL/min/1.73m2)にエキセメスタン25mgを単回経口投与した 後のAUCは、欧米人の閉経後健康女性におけるAUCの約2~3倍であった9)。</p></div>"
             ]
           ], [
             fhir:index 1;
             fhir:Composition.section.title [ fhir:value "16.6.2 肝機能障害患者における体内動態" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "13" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "16.6.2 肝機能障害患者における体内動態" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>中等度又は重度の肝機能障害患者(欧米人の閉経後女性、Child-Pugh分類で B又はC)にエキセメスタン25mgを単回経口投与した後のAUCは、欧米人の 閉経後健康女性におけるAUCの約2~3倍であった9)。</p></div>"
             ]
           ]
         ]
       ], [
         fhir:index 17;
         fhir:Composition.section.title [ fhir:value "17. 臨床成績" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "17" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "17. 臨床成績" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
         ];
         fhir:Composition.section.emptyReason [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "2" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "Section Heading" ]
         ];
         fhir:Composition.section.section [
           fhir:index 0;
           fhir:Composition.section.title [ fhir:value "17.1 有効性及び安全性に関する試験" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "13" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "17.1 有効性及び安全性に関する試験" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
           ];
           fhir:Composition.section.emptyReason [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "2" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "Section Heading" ]
           ];
           fhir:Composition.section.section [
             fhir:index 0;
             fhir:Composition.section.title [ fhir:value "17.1.1 国内臨床試験" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "13" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "17.1.1 国内臨床試験" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>第I相試験において、閉経後健康女性(単回14例、反復25例)を対象として、 本剤の0.5~50mg/日までの用量における安全性及び薬力学的作用(血清中エ ストロゲン濃度抑制作用)を検討した結果、用量依存的な血清中エストロゲ ン濃度の低下が認められた。前期第II相試験において、閉経後乳癌患者(10mg、 25mg各36例)を対象として、本剤の有効性及び安全性を検討の上、臨床推奨 用量の設定を試みた。奏効率において有意差はないものの25mgの方が10mg より優っていたことなどから、本剤の臨床推奨用量として25mg/日を選択した。 ホルモン療法耐性例に対する25mg群の奏効率は26.1%(6/23)であった3,4,10)。</p></div>"
             ]
           ], [
             fhir:index 1;
             fhir:Composition.section.title [ fhir:value "17.1.2 ブリッジング試験" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "13" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "17.1.2 ブリッジング試験" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>後期第II相試験において、抗エストロゲン剤耐性の閉経後乳癌患者33例を対 象として本剤の有効性及び安全性が検討された。なお、本試験は海外にて実 施された同様の試験(No.120002及びNo.010)結果の再現性を確認すること を目的として実施された11~13)。</p><table border=\"1\"><tbody><tr><td style=\"text-align:center\"><p>抗腫瘍効果</p></td><td style=\"text-align:center\"><p>実施国 (試験番号)</p></td><td style=\"text-align:center\"><p>日本<br/>(No.042)</p></td><td style=\"text-align:center\"><p>米国等<br/>(No.120002)</p></td><td style=\"text-align:center\"><p>欧州等<br/>(No.010)</p></td></tr><tr><td colspan=\"2\" style=\"text-align:center\"><p>奏効率<br/>(奏効例/評価例)</p></td><td style=\"text-align:center\"><p>24.2%<br/>(8/33)</p></td><td style=\"text-align:center\"><p>28.1%<br/>(36/128)</p></td><td style=\"text-align:center\"><p>23.4%<br/>(32/137)</p></td></tr><tr><td colspan=\"2\" style=\"text-align:center\"><p>長期NC注1)を含む有効率<br/>(奏効例+長期NC例/評価例)</p></td><td style=\"text-align:center\"><p>39.4%<br/>(13/33)</p></td><td style=\"text-align:center\"><p>46.9%<br/>(60/128)</p></td><td style=\"text-align:center\"><p>47.4%<br/>(65/137)</p></td></tr></tbody></table><p>注1)長期NC:24週以上のNC持続</p></div>"
             ]
           ], [
             fhir:index 2;
             fhir:Composition.section.title [ fhir:value "17.1.3 海外臨床試験(第III相試験)" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "13" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "17.1.3 海外臨床試験(第III相試験)" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>欧米19ヵ国が参加した多施設共同試験において、タモキシフェンに無効と なった閉経後の進行乳癌に対する本剤の抗腫瘍効果及び安全性を、酢酸メゲ ストロール(160mg/日:国内未承認)を対照薬として検討した。抗腫瘍効果 において、奏効率では群間に有意差は認められなかったものの、本剤の奏効 率は15.0%(55/366)であり、酢酸メゲストロール群は12.4%(50/403)であっ た。長期NCを含む有効率はエキセメスタンで37.4%、酢酸メゲストロールで 34.6%であった。さらに本剤の病勢進行までの期間、治療変更等までの期間 及び生存期間は、酢酸メゲストロール群と比較し有意に延長した14) 。</p></div>"
             ]
           ], [
             fhir:index 3;
             fhir:Composition.section.title [ fhir:value "17.1.4 海外大規模比較試験(第III相試験 術後補助療法)" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "13" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "17.1.4 海外大規模比較試験(第III相試験 術後補助療法)" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>海外37ヵ国が参加した多施設共同二重盲検比較試験において、術後補助療法 としてタモキシフェンを2~3年投与した閉経後乳癌患者(4,724例)を対象 とし、タモキシフェン継続群(2,372例)と、本剤に切り替えた本剤投与群 (2,352例)に割り付け、無病生存率及び安全性を検討した(両群とも術後補 助療法としての投与期間:5年間)。その結果、追跡期間(中央値34.5ヵ月) における再発・対側乳癌・死亡発生数は本剤投与群213例、タモキシフェン継 続群306例であり、無病生存率は本剤投与群90%(95%信頼区間89-92%)、タ モキシフェン継続群86%(95%信頼区間85-88%)であった。また、無病生存 期間のハザード比は0.69(95%信頼区間0.58-0.82、p=0.00003)であり、本 剤投与群はタモキシフェン継続群と比較して乳癌再発リスクを31%低下させ た。対側乳癌の発生リスクのハザード比は0.32(本剤投与群8例、タモキシフェ ン継続群25例、95%信頼区間0.15-0.72、p=0.0034)であり、本剤投与群は 対側乳癌のリスクを68%低下させた15)。</p></div>"
             ]
           ], [
             fhir:index 4;
             fhir:Composition.section.title [ fhir:value "17.1.5 海外比較試験(術後補助療法)" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "13" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "17.1.5 海外比較試験(術後補助療法)" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>海外で実施した多施設共同二重盲検比較試験において、再発リスクの低い 乳癌又は腺管上皮内癌(147例)を、本剤投与群(73例)とプラセボ群(74 例)に割り付け、骨密度(Bone Mineral Density)に与える影響及び有効 性、安全性を検討した(投与期間:2年間、追跡期間最長:1年間)。投与2 年後の本剤投与群の腰椎・大腿骨頸部における骨密度の年平均変化率はそ れぞれ-2.17%、-2.72%であり、プラセボ群は-1.84%、-1.48%(p=0.568、 p=0.024)であった。試験中に6例が再発し、1例は本剤投与群、5例がプラセ ボ群であった。また、HDL-コレステロールは本剤投与群(6-9%低下)は、 プラセボ群(1-2%増加)に比較し、有意(p&lt;0.01)に低下したが、他の脂 質パラメータ及び凝固系パラメータでは両群間に差は認められなかった16)。</p></div>"
             ]
           ], [
             fhir:index 5;
             fhir:Composition.section.title [ fhir:value "17.1.6 非盲検無作為化比較試験(第II/III相試験 転移性乳癌に対する第一次 ホルモン療法)" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "16" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "17.1.6 非盲検無作為化比較試験(第II/III相試験 転移性乳癌に対する第一次 ホルモン療法)" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>日本を含む25ヵ国が参加した多施設共同非盲検無作為化比較試験において、 閉経後の転移性乳癌患者382例を対象とし、本剤投与群(190例)とタモキシ フェン投与群(192例)に割り付け、無増悪生存期間を比較検討した。その 結果、本剤投与群の無増悪生存期間が(中央値9.86ヵ月、95%信頼区間8.74- 11.47)タモキシフェン投与群(中央値5.82ヵ月、95%信頼区間5.32-8.08)に 比べて長かったが、統計的に有意な差は認められなかった(log-rank検定 p=0.1214)。また、全生存期間の中央値は、タモキシフェン群が43.3ヵ月 (95%信頼区間34.00-51.55)、本剤投与群が37.2ヵ月(95%信頼区間29.80- 45.47)であったが、統計的に有意な差は認められなかった(log-rank検定 p=0.9198)。さらに副次的評価項目である安全性プロファイルから本剤の忍 容性が確認された17)。</p><p>INSERT IMAGE</p></div>"
             ]
           ]
         ]
       ], [
         fhir:index 18;
         fhir:Composition.section.title [ fhir:value "18. 薬効薬理" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "18" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "18. 薬効薬理" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
         ];
         fhir:Composition.section.emptyReason [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "2" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "Section Heading" ]
         ];
         fhir:Composition.section.section [
           fhir:index 0;
           fhir:Composition.section.title [ fhir:value "18.1 作用機序" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "17" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "18.1 作用機序" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
           ];
           fhir:Composition.section.emptyReason [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "2" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "Section Heading" ]
           ];
           fhir:Composition.section.section [
             fhir:index 0;
             fhir:Composition.section.title [ fhir:value "18.1.1 アロマターゼ阻害作用" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "17" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "18.1.1 アロマターゼ阻害作用" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>エキセメスタンはアンドロゲンをエストロゲンに変換する酵素であるアロマ ターゼを非可逆的に阻害することにより、血中エストロゲン濃度を抑制し、 エストロゲン依存性の乳癌の増殖を阻害する。</p><p>(1)in vivo試験</p><p>妊馬血清ゴナドトロピン刺激ラットにおいて、エキセメスタンの単回経口投与は卵 巣アロマターゼ活性を用量依存的に減少させ、そのED50値は3.7mg/kgであった。</p><p>(2)in vitro試験</p><p>エキセメスタンは、他のステロイド合成系酵素にはほとんど影響を与えるこ となく、アロマターゼを選択的に不活性化した。</p></div>"
             ]
           ]
         ], [
           fhir:index 1;
           fhir:Composition.section.title [ fhir:value "18.2 抗腫瘍効果" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "17" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "18.2 抗腫瘍効果" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>DMBA誘発ラット乳癌(閉経後モデル)に対しエキセメスタンを週6日、4週 間経口投与した結果、1mg/kg/日以上の用量で腫瘍の増殖を有意に阻害した。</p></div>"
           ]
         ], [
           fhir:index 2;
           fhir:Composition.section.title [ fhir:value "18.3 エストロゲン抑制作用" ];
           fhir:Composition.section.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "17" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "18.3 エストロゲン抑制作用" ]
           ];
           fhir:Composition.section.text [
             fhir:Narrative.status [ fhir:value "additional" ];
             fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
           ];
           fhir:Composition.section.emptyReason [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
               fhir:Coding.code [ fhir:value "2" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "Section Heading" ]
           ];
           fhir:Composition.section.section [
             fhir:index 0;
             fhir:Composition.section.title [ fhir:value "18.3.1" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "17" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "18.3.1" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>妊馬血清ゴナドトロピン刺激ラットにおいて、エキセメスタンの単回経 口投与により血漿中エストラジオール濃度は用量依存的に低下し、そのED50 値は3.8mg/kgであった。</p></div>"
             ]
           ], [
             fhir:index 1;
             fhir:Composition.section.title [ fhir:value "18.3.2" ];
             fhir:Composition.section.code [
               fhir:CodeableConcept.coding [
                 fhir:index 0;
                 fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
                 fhir:Coding.code [ fhir:value "17" ]
               ];
               fhir:CodeableConcept.text [ fhir:value "18.3.2" ]
             ];
             fhir:Composition.section.text [
               fhir:Narrative.status [ fhir:value "additional" ];
               fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>閉経後乳癌患者にエキセメスタン25mgを連日経口投与することにより、 血漿又は血清中エストロゲン(エストラジオール、エストロン及びエストロ ンスルフェート)濃度は81~95%低下した。</p></div>"
             ]
           ]
         ]
       ], [
         fhir:index 19;
         fhir:Composition.section.title [ fhir:value "19. 有効成分に関する理化学的知見" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "19" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "19. 有効成分に関する理化学的知見" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>一般的名称:エキセメスタン(Exemestane)</p><p>化学名:(+)-6-methyleneandrosta-1,4-diene-3,17-dione</p><p>分子式:C20H24O2</p><p>分子量:296.40</p><p>性状:白色~黄白色の粉末である。N ,N -ジメチルホルムアミド及びテトラヒ ドロフランに溶けやすく、メタノール及びエタノール(95)にやや溶けやすく、 アセトニトリルにやや溶けにくく、水にほとんど溶けない。</p><p>化学構造式:</p><p><img src=\"figure3-exemestane-chemical-structure.png\"/></p></div>"
         ]
       ], [
         fhir:index 20;
         fhir:Composition.section.title [ fhir:value "20. 取扱い上の注意" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "9" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "20. 取扱い上の注意" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
         ];
         fhir:Composition.section.emptyReason [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "1" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
         ]
       ], [
         fhir:index 21;
         fhir:Composition.section.title [ fhir:value "21. 承認条件" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "9" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "21. 承認条件" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
         ];
         fhir:Composition.section.emptyReason [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "1" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
         ]
       ], [
         fhir:index 22;
         fhir:Composition.section.title [ fhir:value "22. 包装" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "22" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "22. 包装" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>28錠[14錠(PTP)×2]</p><p>140錠[14錠(PTP)×10]</p></div>"
         ]
       ], [
         fhir:index 23;
         fhir:Composition.section.title [ fhir:value "23. 主要文献" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "23" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "23. 主要文献" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ol><li>社内資料:マウスにおける発癌性試験 [L20050107111]</li><li>社内資料:閉経後乳癌患者における薬物動態(2002年7月5日承認、申請資 料概要ヘ.3.1.2、ヘ.3.2.1.iv) [L20070831006]</li><li>三浦 重人ほか:癌と化学療法.2002;29(7):1179-1187</li><li>三浦 重人ほか:癌と化学療法.2002;29(7):1189-1197</li><li>社内資料:臓器・組織内濃度(単回投与)(2002年7月5日承認、申請資料 概要ヘ.2.2.1.i、ヘ.2.2.3.i、ヘ.2.4.4) [L20070831010]</li><li>社内資料:蛋白結合率(2002年7月5日承認、申請資料概要ヘ.2.2.4) [L20070831009]</li><li>社内資料:代謝(2002年7月5日承認、申請資料概要ヘ.2.3、ヘ.3.2.1.vi、ヘ.4) [L20070831007]</li><li>社内資料:健康人における薬物動態(海外データ)(2002年7月5日承認、申 請資料概要ヘ.3.2.1.i) [L20070831008]</li><li>Jannuzzo Maria Gabriella et al.:Cancer Chemother Pharmacol.2004; 53(6):475-481</li><li>田部井 敏夫ほか:癌と化学療法.2002;29(7):1199-1209</li><li>渡辺 亨ほか:癌と化学療法.2002;29(7):1211-1221</li><li>社内資料:第二次療法における第II相試験(海外データ)(2002年7月5日 承認、申請資料概要ト.1.3) [L20070831011]</li><li>Kvinnaland, S. et al.:Eur J Cancer.2000;36(8):976-982</li><li>Kaufmann, M. et al.:J Clin Oncol.2000;18(7):1399-1411</li><li>社内資料:術後補助療法としてタモキシフェンを2から3年間投与された閉 経後原発乳癌患者を対象にエキセメスタン療法への切り替えとタモキシ フェン療法継続とを比較する無作為化二重盲検試験 [L20041214003]</li><li>Lonning, P. E. et al.:J Clin Oncol.2005;23(22):5126-5137</li><li>社内資料:閉経後患者における転移性乳癌に対する第一次ホルモン療法と してのエキセメスタンおよびタモキシフェンを比較する無作為化第II-III 相試験 [L20060111037]</li></ol></div>"
         ]
       ], [
         fhir:index 24;
         fhir:Composition.section.title [ fhir:value "24. 文献請求先及び問い合わせ先" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "24" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "24. 文献請求先及び問い合わせ先" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>ファイザー株式会社 製品情報センター</p><p>〒151-8589 東京都渋谷区代々木3-22-7</p><p>学術情報ダイヤル 0120-664-467</p><p>FAX 03-3379-3053</p></div>"
         ]
       ], [
         fhir:index 25;
         fhir:Composition.section.title [ fhir:value "25. 保険給付上の注意" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "9" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "25. 保険給付上の注意" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
         ];
         fhir:Composition.section.emptyReason [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "1" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
         ]
       ], [
         fhir:index 26;
         fhir:Composition.section.title [ fhir:value "26. 製造販売業者等" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "26" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "26. 製造販売業者等" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
         ];
         fhir:Composition.section.emptyReason [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "2" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "Section Heading" ]
         ]
       ], [
         fhir:index 27;
         fhir:Composition.section.title [ fhir:value "26.1 製造販売元" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "26" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "26.1 製造販売元" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>ファイザー株式会社</p><p>東京都渋谷区代々木3-22-7</p><p><img src=\"figure4-pfizer-logo-small.png\"/></p></div>"
         ]
       ]
     ]
  ], [
     fhir:index 1;
     fhir:Bundle.entry.resource [
       a fhir:Organization;
       fhir:Resource.id [ fhir:value "7f257409-3b65-401d-a246-7ae51e298fbb" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Organization-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Organization-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"7f257409-3b65-401d-a246-7ae51e298fbb\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Organization-uv-epi.html\">Organization (ePI)</a></p></div><p><b>identifier</b>: id: 672212 (OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Manufacturer <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#tbd \"Marketing authorisation holder\")</span></p><p><b>name</b>: Pfizer, Inc.</p><p><b>telecom</b>: ph: 0120-664-467(WORK), fax: 03-3379-3053(WORK)</p><p><b>address</b>: 3-22-7 Yoyogi, Shibuya-ku, Tokyo(WORK)</p></div>"
       ];
       fhir:Organization.identifier [
         fhir:index 0;
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://pmda-org-id" ];
         fhir:Identifier.value [ fhir:value "672212" ]
       ];
       fhir:Organization.active [ fhir:value "true"^^xsd:boolean ];
       fhir:Organization.type [
         fhir:index 0;
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://PMDA-org-type.jp/" ];
           fhir:Coding.code [ fhir:value "tbd" ];
           fhir:Coding.display [ fhir:value "Marketing authorisation holder" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Manufacturer" ]
       ];
       fhir:Organization.name [ fhir:value "Pfizer, Inc." ];
       fhir:Organization.telecom [
         fhir:index 0;
         fhir:ContactPoint.system [ fhir:value "phone" ];
         fhir:ContactPoint.value [ fhir:value "0120-664-467" ];
         fhir:ContactPoint.use [ fhir:value "work" ]
       ], [
         fhir:index 1;
         fhir:ContactPoint.system [ fhir:value "fax" ];
         fhir:ContactPoint.value [ fhir:value "03-3379-3053" ];
         fhir:ContactPoint.use [ fhir:value "work" ]
       ];
       fhir:Organization.address [
         fhir:index 0;
         fhir:Address.use [ fhir:value "work" ];
         fhir:Address.type [ fhir:value "physical" ];
         fhir:Address.text [ fhir:value "3-22-7 Yoyogi, Shibuya-ku, Tokyo" ];
         fhir:Address.line [
           fhir:value "3-22-7 Yoyogi";
           fhir:index 0
         ];
         fhir:Address.city [ fhir:value "Tokyo" ];
         fhir:Address.country [ fhir:value "JP" ]
       ]
     ]
  ], [
     fhir:index 2;
     fhir:Bundle.entry.resource [
       a fhir:RegulatedAuthorization;
       fhir:Resource.id [ fhir:value "15c6f86f-8665-4bd6-86da-a3a61fe16084" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/RegulatedAuthorization-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/RegulatedAuthorization-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"15c6f86f-8665-4bd6-86da-a3a61fe16084\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-RegulatedAuthorization-uv-epi.html\">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: id: 21400AMY00186 (OFFICIAL)</p><p><b>subject</b>: <a href=\"#MedicinalProductDefinition_117616c7-3bcc-4665-8e12-0e93447e679e\">See above (MedicinalProductDefinition/117616c7-3bcc-4665-8e12-0e93447e679e)</a></p><p><b>type</b>: Marketing Authorisation <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000072062)</span></p><p><b>region</b>: Japan <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#jp)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2002-08-01 01:28:17+0000</p><p><b>holder</b>: <a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></p></div>"
       ];
       fhir:RegulatedAuthorization.identifier [
         fhir:index 0;
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://pmda-approvalandlicenseno/" ];
         fhir:Identifier.value [ fhir:value "21400AMY00186" ]
       ];
       fhir:RegulatedAuthorization.subject [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/MedicinalProductDefinition/117616c7-3bcc-4665-8e12-0e93447e679e>;
         fhir:Reference.reference [ fhir:value "MedicinalProductDefinition/117616c7-3bcc-4665-8e12-0e93447e679e" ]
       ];
       fhir:RegulatedAuthorization.type [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "/#100000072062" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Marketing Authorisation" ]
       ];
       fhir:RegulatedAuthorization.region [
         fhir:index 0;
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "urn:iso:std:iso:3166" ];
           fhir:Coding.code [ fhir:value "jp" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Japan" ]
       ];
       fhir:RegulatedAuthorization.status [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "http://hl7.org/fhir/publication-status" ];
           fhir:Coding.code [ fhir:value "active" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Active" ]
       ];
       fhir:RegulatedAuthorization.statusDate [ fhir:value "2002-08-01T13:28:17Z"^^xsd:dateTime ];
       fhir:RegulatedAuthorization.holder [
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
         fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
       ]
     ]
  ], [
     fhir:index 3;
     fhir:Bundle.entry.resource [
       a fhir:MedicinalProductDefinition;
       fhir:Resource.id [ fhir:value "117616c7-3bcc-4665-8e12-0e93447e679e" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/MedicinalProductDefinition-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/MedicinalProductDefinition-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"117616c7-3bcc-4665-8e12-0e93447e679e\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-MedicinalProductDefinition-uv-epi.html\">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: id: 123456</p><p><b>type</b>: Medicinal Product <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-medicinal-product-type.html\">MedicinalProductType</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-medicinal-product-domain.html\">MedicinalProductDomain</a>#Human)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#100000072084)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Aromasin (exemestane) Tablets 25 mg</p><p><b>type</b>: Full name <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#220000000001)</span></p><h3>NameParts</h3><table class=\"grid\"><tr><td>-</td><td><b>Part</b></td><td><b>Type</b></td></tr><tr><td>*</td><td>Tablet</td><td>Pharmaceutical dose form part <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#220000000005)</span></td></tr></table><h3>CountryLanguages</h3><table class=\"grid\"><tr><td>-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td>*</td><td>Japan <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#jp)</span></td><td>Japan <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#jp)</span></td><td>Japanese <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#ja)</span></td></tr></table></blockquote></div>"
       ];
       fhir:MedicinalProductDefinition.identifier [
         fhir:index 0;
         fhir:Identifier.system [ fhir:value "https://spor.ema.europa.eu/pmswi" ];
         fhir:Identifier.value [ fhir:value "123456" ]
       ];
       fhir:MedicinalProductDefinition.type [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "http://hl7.org/fhir/medicinal-product-type" ];
           fhir:Coding.code [ fhir:value "MedicinalProduct" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Medicinal Product" ]
       ];
       fhir:MedicinalProductDefinition.domain [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "http://hl7.org/fhir/medicinal-product-domain" ];
           fhir:Coding.code [ fhir:value "Human" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Human use" ]
       ];
       fhir:MedicinalProductDefinition.status [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "http://hl7.org/fhir/publication-status" ];
           fhir:Coding.code [ fhir:value "active" ];
           fhir:Coding.display [ fhir:value "Active" ]
         ]
       ];
       fhir:MedicinalProductDefinition.legalStatusOfSupply [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi" ];
           fhir:Coding.code [ fhir:value "100000072084" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Medicinal product subject to medical prescription" ]
       ];
       fhir:MedicinalProductDefinition.name [
         fhir:index 0;
         fhir:MedicinalProductDefinition.name.productName [ fhir:value "Aromasin (exemestane) Tablets 25 mg" ];
         fhir:MedicinalProductDefinition.name.type [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi" ];
             fhir:Coding.code [ fhir:value "220000000001" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "Full name" ]
         ];
         fhir:MedicinalProductDefinition.name.namePart [
           fhir:index 0;
           fhir:MedicinalProductDefinition.name.namePart.part [ fhir:value "Tablet" ];
           fhir:MedicinalProductDefinition.name.namePart.type [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi" ];
               fhir:Coding.code [ fhir:value "220000000005" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "Pharmaceutical dose form part" ]
           ]
         ];
         fhir:MedicinalProductDefinition.name.countryLanguage [
           fhir:index 0;
           fhir:MedicinalProductDefinition.name.countryLanguage.country [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "urn:iso:std:iso:3166" ];
               fhir:Coding.code [ fhir:value "jp" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "Japan" ]
           ];
           fhir:MedicinalProductDefinition.name.countryLanguage.jurisdiction [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "urn:iso:std:iso:3166" ];
               fhir:Coding.code [ fhir:value "jp" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "Japan" ]
           ];
           fhir:MedicinalProductDefinition.name.countryLanguage.language [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "urn:iso:std:iso:639-1" ];
               fhir:Coding.code [ fhir:value "ja" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "Japanese" ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 4;
     fhir:Bundle.entry.resource [
       a fhir:PackagedProductDefinition;
       fhir:Resource.id [ fhir:value "bb536b04-39f1-4e0a-a723-e9079fd5e994" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/PackagedProductDefinition-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/PackagedProductDefinition-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"bb536b04-39f1-4e0a-a723-e9079fd5e994\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-PackagedProductDefinition-uv-epi.html\">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: id: 4291012F1022_4_02-001 (OFFICIAL)</p><p><b>name</b>: Aromasin (exemestane) Tablets 25 mg - 28 tablets [14 tablets (PTP) x 2]</p><p><b>type</b>: Chemical Medininal Prodcut <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#100000155527)</span></p><p><b>packageFor</b>: <a href=\"#MedicinalProductDefinition_117616c7-3bcc-4665-8e12-0e93447e679e\">See above (MedicinalProductDefinition/117616c7-3bcc-4665-8e12-0e93447e679e)</a></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2002-08-01 01:28:17+0000</p><p><b>containedItemQuantity</b>: 28 tablet</p><p><b>manufacturer</b>: <a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></p><blockquote><p><b>package</b></p><p><b>identifier</b>: id: 123456</p><p><b>type</b>: Blister <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#30007000)</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: PolyVinyl Chloride <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#200000003222)</span></p><blockquote><p><b>containedItem</b></p></blockquote></blockquote></div>"
       ];
       fhir:PackagedProductDefinition.identifier [
         fhir:index 0;
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://spor.ema.europa.eu/pmswi" ];
         fhir:Identifier.value [ fhir:value "4291012F1022_4_02-001" ]
       ];
       fhir:PackagedProductDefinition.name [ fhir:value "Aromasin (exemestane) Tablets 25 mg - 28 tablets [14 tablets (PTP) x 2]" ];
       fhir:PackagedProductDefinition.type [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi" ];
           fhir:Coding.code [ fhir:value "100000155527" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Chemical Medininal Prodcut" ]
       ];
       fhir:PackagedProductDefinition.packageFor [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/MedicinalProductDefinition/117616c7-3bcc-4665-8e12-0e93447e679e>;
         fhir:Reference.reference [ fhir:value "MedicinalProductDefinition/117616c7-3bcc-4665-8e12-0e93447e679e" ]
       ];
       fhir:PackagedProductDefinition.status [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "http://hl7.org/fhir/publication-status" ];
           fhir:Coding.code [ fhir:value "active" ];
           fhir:Coding.display [ fhir:value "Active" ]
         ]
       ];
       fhir:PackagedProductDefinition.statusDate [ fhir:value "2002-08-01T13:28:17Z"^^xsd:dateTime ];
       fhir:PackagedProductDefinition.containedItemQuantity [
         fhir:index 0;
         fhir:Quantity.value [ fhir:value "28"^^xsd:decimal ];
         fhir:Quantity.unit [ fhir:value "tablet" ]
       ];
       fhir:PackagedProductDefinition.manufacturer [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
         fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
       ];
       fhir:PackagedProductDefinition.package [
         fhir:PackagedProductDefinition.package.identifier [
           fhir:index 0;
           fhir:Identifier.system [ fhir:value "https://spor.ema.europa.eu/pmswi" ];
           fhir:Identifier.value [ fhir:value "123456" ]
         ];
         fhir:PackagedProductDefinition.package.type [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi" ];
             fhir:Coding.code [ fhir:value "30007000" ];
             fhir:Coding.display [ fhir:value "Blister" ]
           ]
         ];
         fhir:PackagedProductDefinition.package.quantity [ fhir:value "1"^^xsd:integer ];
         fhir:PackagedProductDefinition.package.material [
           fhir:index 0;
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi" ];
             fhir:Coding.code [ fhir:value "200000003222" ];
             fhir:Coding.display [ fhir:value "PolyVinyl Chloride" ]
           ]
         ];
         fhir:PackagedProductDefinition.package.containedItem [
           fhir:index 0;
           fhir:PackagedProductDefinition.package.containedItem.item [
             fhir:CodeableReference.reference [
               fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
               fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 5;
     fhir:Bundle.entry.resource [
       a fhir:PackagedProductDefinition;
       fhir:Resource.id [ fhir:value "39307d03-7ff4-4c0d-9326-36de7beb7cad" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/PackagedProductDefinition-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/PackagedProductDefinition-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"39307d03-7ff4-4c0d-9326-36de7beb7cad\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-PackagedProductDefinition-uv-epi.html\">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: id: 4291012F1022_4_02-002 (OFFICIAL)</p><p><b>name</b>: Aromasin (exemestane) Tablets 25 mg - 140 tablets [14 tablets (PTP) x 10]</p><p><b>type</b>: Chemical Medininal Prodcut <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#100000155527)</span></p><p><b>packageFor</b>: <a href=\"#MedicinalProductDefinition_117616c7-3bcc-4665-8e12-0e93447e679e\">See above (MedicinalProductDefinition/117616c7-3bcc-4665-8e12-0e93447e679e)</a></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2002-08-01 01:28:17+0000</p><p><b>containedItemQuantity</b>: 140 tablet</p><p><b>manufacturer</b>: <a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></p><blockquote><p><b>package</b></p><p><b>identifier</b>: id: 78910</p><p><b>type</b>: Blister <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#30007000)</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: PolyVinyl Chloride <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#200000003222)</span></p><blockquote><p><b>containedItem</b></p></blockquote></blockquote></div>"
       ];
       fhir:PackagedProductDefinition.identifier [
         fhir:index 0;
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://pmda-packinsertno/" ];
         fhir:Identifier.value [ fhir:value "4291012F1022_4_02-002" ]
       ];
       fhir:PackagedProductDefinition.name [ fhir:value "Aromasin (exemestane) Tablets 25 mg - 140 tablets [14 tablets (PTP) x 10]" ];
       fhir:PackagedProductDefinition.type [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi" ];
           fhir:Coding.code [ fhir:value "100000155527" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Chemical Medininal Prodcut" ]
       ];
       fhir:PackagedProductDefinition.packageFor [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/MedicinalProductDefinition/117616c7-3bcc-4665-8e12-0e93447e679e>;
         fhir:Reference.reference [ fhir:value "MedicinalProductDefinition/117616c7-3bcc-4665-8e12-0e93447e679e" ]
       ];
       fhir:PackagedProductDefinition.status [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "http://hl7.org/fhir/publication-status" ];
           fhir:Coding.code [ fhir:value "active" ];
           fhir:Coding.display [ fhir:value "Active" ]
         ]
       ];
       fhir:PackagedProductDefinition.statusDate [ fhir:value "2002-08-01T13:28:17Z"^^xsd:dateTime ];
       fhir:PackagedProductDefinition.containedItemQuantity [
         fhir:index 0;
         fhir:Quantity.value [ fhir:value "140"^^xsd:decimal ];
         fhir:Quantity.unit [ fhir:value "tablet" ]
       ];
       fhir:PackagedProductDefinition.manufacturer [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
         fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
       ];
       fhir:PackagedProductDefinition.package [
         fhir:PackagedProductDefinition.package.identifier [
           fhir:index 0;
           fhir:Identifier.system [ fhir:value "https://spor.ema.europa.eu/pmswi" ];
           fhir:Identifier.value [ fhir:value "78910" ]
         ];
         fhir:PackagedProductDefinition.package.type [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi" ];
             fhir:Coding.code [ fhir:value "30007000" ];
             fhir:Coding.display [ fhir:value "Blister" ]
           ]
         ];
         fhir:PackagedProductDefinition.package.quantity [ fhir:value "1"^^xsd:integer ];
         fhir:PackagedProductDefinition.package.material [
           fhir:index 0;
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi" ];
             fhir:Coding.code [ fhir:value "200000003222" ];
             fhir:Coding.display [ fhir:value "PolyVinyl Chloride" ]
           ]
         ];
         fhir:PackagedProductDefinition.package.containedItem [
           fhir:index 0;
           fhir:PackagedProductDefinition.package.containedItem.item [
             fhir:CodeableReference.reference [
               fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
               fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 6;
     fhir:Bundle.entry.resource [
       a fhir:AdministrableProductDefinition;
       fhir:Resource.id [ fhir:value "d43df7b9-7815-4eb5-8350-945e4b77d46b" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/AdministrableProductDefinition-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/AdministrableProductDefinition-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"d43df7b9-7815-4eb5-8350-945e4b77d46b\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-AdministrableProductDefinition-uv-epi.html\">AdministrableProductDefinition (ePI)</a></p></div><p><b>identifier</b>: id: 0x712653c26276d3c31c11a7c198246a38</p><p><b>status</b>: active</p><p><b>formOf</b>: <a href=\"#MedicinalProductDefinition_117616c7-3bcc-4665-8e12-0e93447e679e\">See above (MedicinalProductDefinition/117616c7-3bcc-4665-8e12-0e93447e679e)</a></p><p><b>administrableDoseForm</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#10219000)</span></p><p><b>unitOfPresentation</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#15054000)</span></p><p><b>producedFrom</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#20053000)</span></p><h3>TargetSpecies</h3><table class=\"grid\"><tr><td>-</td><td><b>Code</b></td></tr><tr><td>*</td><td>Human <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-CodeSystemUvEPIRrmswi.html\">Referentials Management Services CodeSystem</a>#100000109093)</span></td></tr></table></blockquote></div>"
       ];
       fhir:AdministrableProductDefinition.identifier [
         fhir:index 0;
         fhir:Identifier.system [ fhir:value "https://www.who-umc.org/phpid" ];
         fhir:Identifier.value [ fhir:value "0x712653c26276d3c31c11a7c198246a38" ]
       ];
       fhir:AdministrableProductDefinition.status [ fhir:value "active" ];
       fhir:AdministrableProductDefinition.formOf [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/MedicinalProductDefinition/117616c7-3bcc-4665-8e12-0e93447e679e>;
         fhir:Reference.reference [ fhir:value "MedicinalProductDefinition/117616c7-3bcc-4665-8e12-0e93447e679e" ]
       ];
       fhir:AdministrableProductDefinition.administrableDoseForm [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi" ];
           fhir:Coding.code [ fhir:value "10219000" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Tablet" ]
       ];
       fhir:AdministrableProductDefinition.unitOfPresentation [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi" ];
           fhir:Coding.code [ fhir:value "15054000" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Tablet" ]
       ];
       fhir:AdministrableProductDefinition.producedFrom [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:AdministrableProductDefinition.routeOfAdministration [
         fhir:index 0;
         fhir:AdministrableProductDefinition.routeOfAdministration.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi" ];
             fhir:Coding.code [ fhir:value "20053000" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "Oral use" ]
         ];
         fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies [
           fhir:index 0;
           fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.code [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi" ];
               fhir:Coding.code [ fhir:value "100000109093" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "Human" ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 7;
     fhir:Bundle.entry.resource [
       a fhir:ManufacturedItemDefinition;
       fhir:Resource.id [ fhir:value "7460b712-82ad-4cce-a756-90b0fa04896c" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/ManufacturedItemDefinition-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/ManufacturedItemDefinition-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"7460b712-82ad-4cce-a756-90b0fa04896c\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ManufacturedItemDefinition-uv-epi.html\">ManufacturedItemDefinition (ePI)</a></p></div><p><b>identifier</b>: id: 874291 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>manufacturedDoseForm</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#10219000)</span></p><p><b>unitOfPresentation</b>: Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#15054000)</span></p><p><b>manufacturer</b>: <a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></p></div>"
       ];
       fhir:ManufacturedItemDefinition.identifier [
         fhir:index 0;
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://pmda-sccj" ];
         fhir:Identifier.value [ fhir:value "874291" ]
       ];
       fhir:ManufacturedItemDefinition.status [ fhir:value "active" ];
       fhir:ManufacturedItemDefinition.manufacturedDoseForm [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://standardterms.edqm.eu/browse/get_concepts_by/SOM/SOM/" ];
           fhir:Coding.code [ fhir:value "10219000" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Tablet" ]
       ];
       fhir:ManufacturedItemDefinition.unitOfPresentation [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://standardterms.edqm.eu/browse/get_concepts/UOP/" ];
           fhir:Coding.code [ fhir:value "15054000" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Tablet" ]
       ];
       fhir:ManufacturedItemDefinition.manufacturer [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
         fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
       ]
     ]
  ], [
     fhir:index 8;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "41089f24-89ce-4fda-a038-70f3cd28ab06" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"41089f24-89ce-4fda-a038-70f3cd28ab06\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: NY22HMQ4BX (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#00000072072)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p><h3>Strengths</h3><table class=\"grid\"><tr><td>-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td>*</td><td>25 mg</td><td>active ingredient - basis of strength <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (v3-RoleClassIngredientEntity#ACTIB)</span></td></tr></table></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "NY22HMQ4BX" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "00000072072" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "active" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "NY22HMQ4BX" ];
               fhir:Coding.display [ fhir:value "exemestane" ]
             ]
           ]
         ];
         fhir:Ingredient.substance.strength [
           fhir:index 0;
           fhir:Ingredient.substance.strength.presentationQuantity [
             fhir:Quantity.value [ fhir:value "25"^^xsd:decimal ];
             fhir:Quantity.unit [ fhir:value "mg" ]
           ];
           fhir:Ingredient.substance.strength.basis [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "http://terminology.hl7.org/ValueSet/v3-RoleClassIngredientEntity" ];
               fhir:Coding.code [ fhir:value "ACTIB" ]
             ];
             fhir:CodeableConcept.text [ fhir:value "active ingredient - basis of strength" ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 9;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "b3773440-614c-4007-bc1c-2fec305b6b81" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"b3773440-614c-4007-bc1c-2fec305b6b81\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: R12CBM0EIZ (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "R12CBM0EIZ" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "100000072082" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Excipient" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "R12CBM0EIZ" ];
               fhir:Coding.display [ fhir:value "Carnauba wax" ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 10;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "aceb61f1-4030-458c-996c-3707c919a0e2" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"aceb61f1-4030-458c-996c-3707c919a0e2\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: OP1R32D61U (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "OP1R32D61U" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "100000072082" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Excipient" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "OP1R32D61U" ];
               fhir:Coding.display [ fhir:value "crystalline cellulose" ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 11;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "868c0677-e53b-4f0d-a6aa-a7473756b8e9" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"868c0677-e53b-4f0d-a6aa-a7473756b8e9\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: 3OWL53L36A (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "3OWL53L36A" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "100000072082" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Excipient" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "3OWL53L36A" ];
               fhir:Coding.display [ fhir:value "MANNITOL" ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 12;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "fc31fc43-2825-41c6-8757-e1c0cab29712" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"fc31fc43-2825-41c6-8757-e1c0cab29712\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: 3NXW29V3WO (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "3NXW29V3WO" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "100000072082" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Excipient" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "3NXW29V3WO" ];
               fhir:Coding.display [ fhir:value "HYPROMELLOSE, UNSPECIFIED " ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 13;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "aba217d4-5bc4-4690-b100-401cae4390ed" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"aba217d4-5bc4-4690-b100-401cae4390ed\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: ETJ7Z6XBU4 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "ETJ7Z6XBU4" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "100000072082" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Excipient" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "ETJ7Z6XBU4" ];
               fhir:Coding.display [ fhir:value "light anhydrous silicic acid" ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 14;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "77f5c3de-eeb4-441f-b37b-f66a4a9bfdc7" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"77f5c3de-eeb4-441f-b37b-f66a4a9bfdc7\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: 0E53J927NA (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "0E53J927NA" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "100000072082" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Excipient" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "0E53J927NA" ];
               fhir:Coding.display [ fhir:value "MAGNESIUM CARBONATE" ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 15;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "ad9f21be-db44-4f3d-80fb-8d61722ef070" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"ad9f21be-db44-4f3d-80fb-8d61722ef070\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: 70097M6I30 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "70097M6I30" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "100000072082" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Excipient" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "70097M6I30" ];
               fhir:Coding.display [ fhir:value "MAGNESIUM STEARATE" ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 16;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "570a14b4-3e58-4afc-9cc1-4d4b38bcd485" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"570a14b4-3e58-4afc-9cc1-4d4b38bcd485\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: A2I8C7HI9T (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "A2I8C7HI9T" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "100000072082" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Excipient" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "A2I8C7HI9T" ];
               fhir:Coding.display [ fhir:value "METHYLPARABEN" ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 17;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "c33a68c8-aecc-4556-8632-e2f3f7ba5b5a" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"c33a68c8-aecc-4556-8632-e2f3f7ba5b5a\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: 30IQX730WE (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "30IQX730WE" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "100000072082" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Excipient" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "30IQX730WE" ];
               fhir:Coding.display [ fhir:value "POLYETHYLENE GLYCOL 6000" ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 18;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "65bb58dd-b083-4cd3-892f-60fed75967d5" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"65bb58dd-b083-4cd3-892f-60fed75967d5\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: 6OZP39ZG8H (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "6OZP39ZG8H" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "100000072082" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Excipient" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "6OZP39ZG8H" ];
               fhir:Coding.display [ fhir:value "POLYSORBATE 80" ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 19;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "9df66779-105d-4df6-b920-a3d134cec967" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"9df66779-105d-4df6-b920-a3d134cec967\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: 532B59J990 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "532B59J990" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "100000072082" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Excipient" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "532B59J990" ];
               fhir:Coding.display [ fhir:value "POLYVINYL ALCOHOL, UNSPECIFIED" ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 20;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "f4d45370-a6f1-4c35-a82a-f64982ab89b3" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"f4d45370-a6f1-4c35-a82a-f64982ab89b3\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: C151H8M554 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "C151H8M554" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "100000072082" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Excipient" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "C151H8M554" ];
               fhir:Coding.display [ fhir:value "SUCROSE" ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 21;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "86746372-3005-4ba0-a2d0-bcd0d55e56a0" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"86746372-3005-4ba0-a2d0-bcd0d55e56a0\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: ETJ7Z6XBU4 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "ETJ7Z6XBU4" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "100000072082" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Excipient" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "ETJ7Z6XBU4" ];
               fhir:Coding.display [ fhir:value "SILICON DIOXIDE" ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 22;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "8d6832f1-7d1d-483b-a0fd-879d531681fb" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"8d6832f1-7d1d-483b-a0fd-879d531681fb\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: 5856J3G2A2 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "5856J3G2A2" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "100000072082" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Excipient" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "5856J3G2A2" ];
               fhir:Coding.display [ fhir:value "SODIUM STARCH GLYCOLATE TYPE A POTATO" ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 23;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "13beb88f-1df3-499d-9c74-4f5925a6f206" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"13beb88f-1df3-499d-9c74-4f5925a6f206\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: 5M631N9V0S (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "5M631N9V0S" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "100000072082" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Excipient" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "5M631N9V0S" ];
               fhir:Coding.display [ fhir:value "synthetic wax" ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 24;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "42a65fd0-6ba9-4b81-9cc2-4c9754d56a95" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"42a65fd0-6ba9-4b81-9cc2-4c9754d56a95\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: 7SEV7J4R1U (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "7SEV7J4R1U" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "100000072082" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Excipient" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "7SEV7J4R1U" ];
               fhir:Coding.display [ fhir:value "talc" ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 25;
     fhir:Bundle.entry.resource [
       a fhir:Ingredient;
       fhir:Resource.id [ fhir:value "cbb53556-9c1f-4fa7-b2af-2eea988dee2d" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Ingredient-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"cbb53556-9c1f-4fa7-b2af-2eea988dee2d\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id: 15FIX9V2JP (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href=\"#ManufacturedItemDefinition_7460b712-82ad-4cce-a756-90b0fa04896c\">See above (ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c)</a></p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000072082)</span></p><h3>Manufacturers</h3><table class=\"grid\"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>"
       ];
       fhir:Ingredient.identifier [
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "15FIX9V2JP" ]
       ];
       fhir:Ingredient.status [ fhir:value "active" ];
       fhir:Ingredient.for [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c>;
         fhir:Reference.reference [ fhir:value "ManufacturedItemDefinition/7460b712-82ad-4cce-a756-90b0fa04896c" ]
       ];
       fhir:Ingredient.role [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/rmswi/" ];
           fhir:Coding.code [ fhir:value "100000072082" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Excipient" ]
       ];
       fhir:Ingredient.manufacturer [
         fhir:index 0;
         fhir:Ingredient.manufacturer.manufacturer [
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
           fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
         ]
       ];
       fhir:Ingredient.substance [
         fhir:Ingredient.substance.code [
           fhir:CodeableReference.concept [
             fhir:CodeableConcept.coding [
               fhir:index 0;
               fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
               fhir:Coding.code [ fhir:value "15FIX9V2JP" ];
               fhir:Coding.display [ fhir:value "TITANIUM DIOXIDE " ]
             ]
           ]
         ]
       ]
     ]
  ], [
     fhir:index 26;
     fhir:Bundle.entry.resource [
       a fhir:SubstanceDefinition;
       fhir:Resource.id [ fhir:value "f733a07f-c7fb-43eb-9776-ec0a3e4748da" ];
       fhir:Resource.meta [
         fhir:Meta.profile [
           fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/SubstanceDefinition-uv-epi";
           fhir:index 0;
           fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/SubstanceDefinition-uv-epi>
         ]
       ];
       fhir:DomainResource.text [
         fhir:Narrative.status [ fhir:value "generated" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"f733a07f-c7fb-43eb-9776-ec0a3e4748da\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-SubstanceDefinition-uv-epi.html\">SubstanceDefinition (ePI)</a></p></div><p><b>identifier</b>: id: NY22HMQ4BX (OFFICIAL)</p><p><b>version</b>: 39</p><p><b>status</b>: Validated (UNII) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#1)</span></p><p><b>description</b>: White to yellowish white It is a powder of. N ,N -Slightly soluble in dimethylformamide and tetrahydroflan, slightly soluble in methanol and ethanol (95), sparingly soluble in acetonitrile, and practically insoluble in water.</p><p><b>manufacturer</b>: <a href=\"#Organization_7f257409-3b65-401d-a246-7ae51e298fbb\">See above (Organization/7f257409-3b65-401d-a246-7ae51e298fbb)</a></p><h3>MolecularWeights</h3><table class=\"grid\"><tr><td>-</td><td><b>Type</b></td><td><b>Amount</b></td></tr><tr><td>*</td><td>exact <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></td><td>296.4</td></tr></table><h3>Structures</h3><table class=\"grid\"><tr><td>-</td><td><b>MolecularFormula</b></td></tr><tr><td>*</td><td>C20H24O2</td></tr></table><h3>Names</h3><table class=\"grid\"><tr><td>-</td><td><b>Name</b></td><td><b>Type</b></td></tr><tr><td>*</td><td>(+)-6-methyleneandrosta-1,4-diene-3,17-dione</td><td>Chemical Name <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#1)</span></td></tr></table></div>"
       ];
       fhir:SubstanceDefinition.identifier [
         fhir:index 0;
         fhir:Identifier.use [ fhir:value "official" ];
         fhir:Identifier.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
         fhir:Identifier.value [ fhir:value "NY22HMQ4BX" ]
       ];
       fhir:SubstanceDefinition.version [ fhir:value "39" ];
       fhir:SubstanceDefinition.status [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
           fhir:Coding.code [ fhir:value "1" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Validated (UNII)" ]
       ];
       fhir:SubstanceDefinition.description [ fhir:value "White to yellowish white It is a powder of. N ,N -Slightly soluble in dimethylformamide and tetrahydroflan, slightly soluble in methanol and ethanol (95), sparingly soluble in acetonitrile, and practically insoluble in water." ];
       fhir:SubstanceDefinition.manufacturer [
         fhir:index 0;
         fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
         fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
       ];
       fhir:SubstanceDefinition.molecularWeight [
         fhir:index 0;
         fhir:SubstanceDefinition.molecularWeight.type [
           fhir:CodeableConcept.text [ fhir:value "exact" ]
         ];
         fhir:SubstanceDefinition.molecularWeight.amount [
           fhir:Quantity.value [ fhir:value "296.4"^^xsd:decimal ]
         ]
       ];
       fhir:SubstanceDefinition.structure [
         fhir:SubstanceDefinition.structure.molecularFormula [ fhir:value "C20H24O2" ]
       ];
       fhir:SubstanceDefinition.name [
         fhir:index 0;
         fhir:SubstanceDefinition.name.name [ fhir:value "(+)-6-methyleneandrosta-1,4-diene-3,17-dione" ];
         fhir:SubstanceDefinition.name.type [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://gsrs.ncats.nih.gov/ginas/app/beta/" ];
             fhir:Coding.code [ fhir:value "1" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "Chemical Name" ]
         ]
       ]
     ]
  ] .

# - ontology header ------------------------------------------------------------

<http://hl7.eu/fhir/ig/gravitate-health/Bundle/33d34b6a-afaf-47d9-8848-366768bd429a.ttl> a owl:Ontology;
  owl:imports fhir:fhir.ttl .

# -------------------------------------------------------------------------------------

